Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T20:54:05.293Z Has data issue: false hasContentIssue false
  • English
  • Français

an Economic Burden Comparison of Typical and Atypical Antipsychotic Therapies for Schizophrenia between General Hospital and Psychiatric Hospital

Published online by Cambridge University Press:  16 April 2020

B. Han ,
R. Tang ,
H. Sun ,
S. Zhao  and
M. Xu
B. Han
Affiliation:
Department of Psychiatry, the First Hospital, Shanxi Medical University, Taiyuan City, China Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, China
R. Tang
Affiliation:
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, China
H. Sun
Affiliation:
Department of Psychiatry, the First Hospital, Shanxi Medical University, Taiyuan City, China
S. Zhao
Affiliation:
Department of Psychiatry, the First Hospital, Shanxi Medical University, Taiyuan City, China
M. Xu
Affiliation:
Department of Psychiatry, the First Hospital, Shanxi Medical University, Taiyuan City, China

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims:

To compare efficacy and medical costs of typital and atypical antipsychotics in treating schizophrenic patients.

Methods:

250 in patients in general hospital and psychiatric hospital were randomly allocated to one of the two groups, one treated with typital antipsychotics as chlorpromazine, haloperidol and so on with a mean daily dose of 500∼800 mg in chlorpromazine equivalents, and the other with atypical agents in cluding clozapine (mean daily dose of 400∼800mg ), risperidone of 6 mg, or olanzapine of 20 mg.

Results:

The total costs of the treatment were (3157±253) Yuan RMB for patients treated with typical agents in general hospital, and (3673±294) Yuan RMB for patients treated with typical agents in psychiatric hospital respectively. the costs for medicine were (774±903) Yuan RMB, (1061±903) Yuan RMB respectively. the costs in atypical group were(1120±390) Yuan RMB and (1637±325) Yuan RMB, and (108±157) Yuan RMB and (240±317) Yuan RMB respectively. the duration of patients treated with typical agents in hospital is longer than that with atypical agents.

Conclusions:

It indicates that atypical antipsychotics have similar efficacy to typical agents in treating schizophrenic patients with less costs.

Type
P03-145
Information
European Psychiatry , Volume 24 , Issue S1: 17th EPA Congress - Lisbon, Portugal, January 2009, Abstract book , January 2009 , 24-E1144
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.